Various examples disclosed relate to temperature monitoring of medical probes. The present disclosure includes a medical device including a medical probe and one or more luminescent marks. The medical probe can include a distal portion configured for at least partial insertion into a patient. The one or more luminescent marks can be located on the distal portion of the probe and have a luminescent characteristic correlative to temperature, when illuminated. The luminescent characteristic can provide an indication of the temperature at an internal site of the patient.

Ablation systems and methods detect and address distortion caused by a variety of factors. A method includes measuring a temperature curve at target tissue; applying ablation energy to the target tissue; determining a peak temperature on the temperature curve; if the peak temperature is greater than the predetermined peak temperature, determining a time at which the temperature curve crosses to a lower temperature; and if the determined time is greater than a predetermined time, generating a message indicating that the target tissue was successfully ablated. Another method includes determining a distance between a remote temperature probe and an ablation probe, applying ablation energy to target tissue, measuring temperature at the remote temperature probe, estimating ablation size based on the determined distance and the temperature measured by the remote temperature probe, and determining whether the target tissue is successfully ablated based on the estimated ablation size.

An energy delivery system comprises a transmission member and an antenna at a distal end of the transmission member. The antenna includes a first conductive arm, an insulator extending around the first conductive arm, and a second conductive arm. The second conductive arm includes a coil. The system also comprises a barrier layer surrounding the transmission member and antenna. The barrier layer extends from a proximal portion of the transmission member to a distal portion of the antenna. The system also comprises a jacket surrounding the barrier layer and forming a fluid channel for receipt of a cooling fluid.

A system for delivering energy to a patient's body is disclosed that includes a plurality of probes, a touch-sensitive display screen, and a controller communicatively coupled to each of the probes and the display screen. The controller is configured to perform operations including displaying a virtual control object in the user interface of the touch-sensitive display screen that is associated with an operating parameter of a treatment procedure performed with the probe. The controller is configured to adjust the operating parameter when a user touch action is directed to the virtual control object. The controller is configured to convert the virtual control object into a non-control label based, at least in part, on a current status of the treatment procedure. The controller is configured to prohibit adjustment of the operating parameter using the non-control label in response to a user touch action that is directed to the non-control label.

The disclosure describes a cryogenic device with a display device for displaying one of a plurality of user-interfaces associated with a plurality of cryogenic device states. The cryogenic device is configured to: generate an initial user-interface for display on the display device; determine that the cryogenic device is in a first state; generate, in response to determining that the cryogenic device is in the first state, instructions for rendering a first user-interface, wherein the first user-interface is associated with the first state; and cause the display device to display the first user-interface. In this way, the cryogenic device may have a dynamic user interface that is configured to response to states of the cryogenic device.

A radio-frequency ablation instrument (100) and a control method and a control apparatus (30) thereof, a system, an electronic device (90) and a storage medium are provided. The control method includes: acquiring at least one current ablation parameter (S701); calculating a power value needed to be outputted in a next cycle according to the current ablation parameter (S702); acquiring an input control voltage corresponding to the power value according to the power value needed to be outputted (S703); and controlling the radio-frequency energy output according to the input control voltage (S704).

Systems and methods are provided for modeling and for providing a graphical representation of tissue heating and electric field distributions for medical treatment devices that apply electrical treatment energy through one or a plurality of electrodes. In embodiments, methods comprise: providing one or more parameters of a treatment protocol for delivering one or more electrical pulses to tissue through a plurality of electrodes; modeling electric and heat distribution in the tissue based on the parameters; and displaying a graphical representation of the modeled electric and heat distribution. In another embodiment, a treatment planning module is adapted to generate an estimated target ablation zone based on a combination of one or more parameters for an irreversible electroporation protocol and one or more tissue-specific conductivity parameters.

Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.

Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.

A processor of an electric power source device exercises control over a power output before a control switching time point based on a value related to initial impedance, and determines the control switching time point upon detecting that a value related to impedance of a living tissue is at a minimum. The processor sets a set electric-power value of the power output based on a parameter related to controlling the power output before the control switching time point, and performs constant-electric-power control by controlling the power output using the electric-power value at and after the control switching time point.